Precipio, Inc.
Close on Oct 19, 2026
- Market cap
- $39.12M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 14, 2026 | During market hours | $7.00M | – | – |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 27, 2026 | During market hours | $6.70M | – | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 15, 2025 | During market hours | $4.90M | – | – |
| Q4 FY2021 Ended Dec 31, 2021 | Feb 28, 2022 | During market hours | – | – | – |
| Q2 FY2021 Ended Jun 30, 2021 | Jul 28, 2021 | During market hours | – | – | – |
| Q2 FY2020 Ended Jun 30, 2020 | Jul 22, 2020 | During market hours | – | – | – |
| Q4 FY2018 Ended Dec 31, 2018 | Feb 14, 2019 | During market hours | – | – | – |
| Q3 FY2018 Ended Sep 30, 2018 | Oct 16, 2018 | During market hours | – | – | – |
| Q2 FY2018 Ended Jun 30, 2018 | Jul 18, 2018 | During market hours | – | – | – |
| Q1 FY2018 Ended Mar 31, 2018 | May 14, 2018 | During market hours | – | – | – |
| Q4 FY2017 Ended Dec 31, 2017 | Feb 9, 2018 | Before market open | – | – | – |
| Q3 FY2017 Ended Sep 30, 2017 | Nov 21, 2017 | Before market open | – | – | – |
Press releases
Announcements Precipio filed with the SEC
Revenue reaches quarterly record as Precipio returns to positive Adjusted EBITDA and strengthens
Results of operations · EX-99.1 to Form 8-K
Announces Q2-2026 Shareholder Update Call
Regulation FD disclosure · EX-99.1 to Form 8-K
Announces Q1-2026 Shareholder Update Call
Regulation FD disclosure · EX-99.1 to Form 8-K
2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year
Results of operations · EX-99.1 to Form 8-K
Announces Q3-2025 Shareholder Update Call
Regulation FD disclosure · EX-99.1 to Form 8-K
T HE RELEVANT PERSON’S PROFESSIONAL ADVISERS) OR PUBLISHED IN W HOLE OR IN PART FOR ANY PURPOSE W IT HOUT T HE PRIOR W RIT T EN CONSENT OF T HE COMPANY.
Regulation FD disclosure · EX-99.1 to Form 8-K
Announces Q2-2025 Shareholder Update Call
Regulation FD disclosure · EX-99.1 to Form 8-K
Conference call to follow tomorrow, May 15 at 5
Results of operations · EX-99.1 to Form 8-K
Announces Q1-2025 Shareholder Update Call
Regulation FD disclosure · EX-99.1 to Form 8-K
Announces Q4 and year-end 2024 Shareholder Update Call
Regulation FD disclosure · EX-99.1 to Form 8-K
management performance-based awards instead of traditional time-vested ESOPs
Regulation FD disclosure · EX-99.1 to Form 8-K
Announces Q3-2024 Shareholder Update Call
Regulation FD disclosure · EX-99.1 to Form 8-K
Call to be held on August 19, 2024 at 5:00 PM EST
Regulation FD disclosure · EX-99.1 to Form 8-K
temporary cashflow deficit related to cash collections delay due to Change Healthcare cybersecurity attack
Material agreement · New financial obligation · Regulation FD disclosure · EX-99.1 to Form 8-K
Year end 2023 Shareholder Update Call
Regulation FD disclosure · EX-99.1 to Form 8-K
Christina Valauri joins the Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Shares Thoughts on 2023, and Looks Ahead To 2024
Regulation FD disclosure · EX-99.1 to Form 8-K
Call to be held on November 20 th , 2023 at 5:00 PM EST
Regulation FD disclosure · EX-99.1 to Form 8-K
Takes Final Step Towards Regaining Nasdaq Compliance
Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
Call to be held on August 17, 2023 at 5:00 PM EST
Regulation FD disclosure · EX-99.1 to Form 8-K
Precipio, Inc. Announces Pricing of $2 Million
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Call to be held on May 17, 2023 at 5:00 PM EST
Regulation FD disclosure · EX-99.1 to Form 8-K
2022 Fourth Quarter and Year-End
Regulation FD disclosure · EX-99.1 to Form 8-K
Third Quarter Shareholder Update Call
Regulation FD disclosure · EX-99.1 to Form 8-K
Announces Second Quarter Shareholder Update Call
Regulation FD disclosure · EX-99.1 to Form 8-K
to distribute HemeScreen® through Fisher Healthcare channel
Regulation FD disclosure · EX-99.1 to Form 8-K
Precipio requests that all Stockholders that
Other events · EX-99.1 to Form 8-K
A Cancer Diagnostics Solutions Company
Regulation FD disclosure · EX-99.1 to Form 8-K
2021 Fourth Quarter and Year-End
Regulation FD disclosure · EX-99.1 to Form 8-K
the Resignation of its Chief Financial Officer and Appointment of Interim CFO
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
2021 Preliminary Unaudited Results and Outlook for 2022
Results of operations · EX-99.1 to Form 8-K
Call to be held on Monday, November 15 th , 2021 at 5:00 PM EST
Regulation FD disclosure · EX-99.1 to Form 8-K